Navigation Links
Anadys Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598)
Date:6/1/2011

, setrobuvir (ANA598) is being tested in combination with Pegasys® and Copegus® in both treatment-naive patients and patients who failed a prior course of therapy with interferon and ribavirin.  Dosing is underway and approximately 275 patients are expected to be enrolled in the study.  The primary endpoint of the study is Sustained Virological Response 24 weeks after patients complete treatment, known as SVR24.  The Company expects to receive antiviral response data through 12 weeks for all patients, including the 8 week timepoint used for response-guided therapy in treatment-naive patients, in the third quarter of 2011.  Antiviral response data through 24 weeks are expected in the fourth quarter of 2011.  

Prior Clinical and Preclinical Profile of Setrobuvir (ANA598)

In an earlier Phase IIa study, setrobuvir (ANA598) demonstrated potent antiviral activity, as well as good safety and tolerability in combination with interferon and ribavirin through 12 weeks of dosing in treatment-naive genotype 1 HCV patients.  In a completed Phase I study, setrobuvir demonstrated potent antiviral activity in a three day monotherapy study in treatment-naive genotype 1 patients.  To date, setrobuvir has demonstrated an excellent resistance profile in HCV patients.

Setrobuvir (ANA598) has also been characterized in a variety of preclinical studies.  In completed long-term chronic toxicology tests in both rats and monkeys, the No Observed Adverse Effect Level, or NOAEL, was 1000 mg/kg, the highest dose tested.  Data from preclinical models of antiviral activity have laid the foundation for clinical investigation of setrobuvir (ANA598) in DAA combinations.  In particular, synergistic antiviral activity in vitro was observed when setrobuvir (ANA598) was combined with a number of approved or investigational HCV agents, and in vitro combinations of setrobuvir (ANA598) with other DAAs from
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights
2. Anadys Pharmaceuticals Appoints Barry Labinger to Its Board of Directors
3. Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
4. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
5. Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference
6. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
7. Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
8. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
9. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
10. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... LOS ANGELES , May 4, 2015 ... on FOX News online last week where he discussed ... device to be FDA-cleared. The FOX segment shows firsthand ... effective and affordable hair loss solution that will not ... light stimulates the mitochondria at the base of the ...
(Date:5/4/2015)... , May 4, 2015 Thirty-six million ... seek help. During May – National Hearing Month – ... could be missing out on the sounds of spring, ... trees. To ensure that you won,t be ... color our world, Oticon, Inc. offers practical advice: ...
(Date:5/4/2015)... , May 4, 2015 ... private equity firm, announced today that it ... company, BioPharm Communications. BioPharm specializes in the development ... for the pharmaceutical and biotechnology industries. ... to its shareholders half of their invested ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2It's Better Hearing Month 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... Jan. 9 ESBATech AG, a leading developer of ... the Phase I/IIa clinical development of its anti-TNF ... double-blind, randomized, placebo-controlled Phase I/IIa clinical study is ... on pain with ESBA105 applied locally via intra-articular ...
... If you are taking prescription medicine,and forgot to ... people taking,prescription medicine don,t take it as prescribed. The ... priorities, or make a conscious,decision not to. Noncompliance has ... Surgeon General Everett Koop commented, "Drugs don,t,work in people ...
Cached Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4Good Medicine: Smarter Smartphones for People With Chronic Disease 2
(Date:5/4/2015)... Greifensee, Switzerland (PRWEB) May 04, 2015 ... entitled “ The Importance of Data Integrity in ... Bob McDowall as guest presenter. This webinar will ... EDT (15:00 GMT). , Data integrity is a ... information submitted to regulatory agencies. However, in recent ...
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... 2015 CCL, a top-ranked, global provider ... program to other leadership development consultancies. “The CCL ... and successful practitioners, expanding our capacity to drive results ... John R. Ryan, CCL President and CEO. , As ... Partner Network , it will schedule a one-on-one conference ...
(Date:5/4/2015)... 04, 2015 New West Medicare is ... Care, LLC to manage outpatient advanced imaging services for ... Medicare ensure its members are provided the right test ... Working closely with New West Medicare’s physicians and hospitals, ... use of advanced imaging and provide an objective basis ...
(Date:5/4/2015)... Sylvia Hawthorn-Deppen shared her experiences living with ... others in similar situations that they were not alone, in ... Discovery of New Energy” (published by Balboa Press). This year ... renewed press campaign. , “I have spent nearly 60 years ... says. “As an adolescent I got into trouble with an ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2
... Scientists have identified a small family of lab-made proteins ... including the H5N1 avian virus, the 1918 pandemic influenza ... antibodies, identical infection-fighting proteins derived from the same cell ... caused by H5N1 and other influenza A viruses. Because ...
... as Charitable Partner for National Initiative as Part of ... NEWPORT NEWS, Va., Feb. 22 The Patient Advocate ... patient services to tens of thousands of patients every ... because of financial or insurance denials - is pleased ...
... 22 Statement of Eliseo Medina and David Regan, Trustees ... Labor Report that the National Labor Relations Board has blocked ... UHW to weaken their former local. The NLRB also ... after learning that the ousted leaders of UHW had failed ...
... have begun to solve some of the mysteries of ... the genetic codes for all the known strains of ... School of Medicine in Baltimore and colleagues at the ... the viruses and assembled them into a "family tree," ...
... better balance in a slippery situation , , FRIDAY, Feb. ... where the footing is unstable helped train them to ... says a University of Illinois at Chicago study. ... develops fall prevention strategies that can be used in ...
... During the annual Promesa y ... leading Spanish-language radio group, Hispanics across the country opened their ... Jude Children,s Research Hospital (R), one of the world,s premier ... Promesa y Esperanza generated more than $6 million ...
Cached Medicine News:Health News:Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu 2Health News:Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu 3Health News:Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu 4Health News:Patient Advocate Foundation Partners with Breakaway from Cancer, Raising Awareness and Funds for Free Services Available to Cancer Patients 2Health News:Patient Advocate Foundation Partners with Breakaway from Cancer, Raising Awareness and Funds for Free Services Available to Cancer Patients 3Health News:Researchers crack the code of the common cold 2Health News:Researchers crack the code of the common cold 3Health News:Researchers crack the code of the common cold 4Health News:Adapting Gait May Help Elderly Avoid Falls 2Health News:Hispanics Across the Country Pledge More Than $6 Million During Univision Radio Event to Help St. Jude Fight Childhood Cancer 2Health News:Hispanics Across the Country Pledge More Than $6 Million During Univision Radio Event to Help St. Jude Fight Childhood Cancer 3
... physician preference card system as well as ... the supply management requirements of the surgical ... with a broad array of inventory management ... operating suite supply and charge capture workflow. ...
... Esteem™ External Vacuum Therapy System restores sexual ... men. Non-invasive and low cost vacuum therapy, ... desirable outcome", makes it the ideal therapy ... Therapy System causes penile rigidity that can ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
... The D.O.R.C. Associate is an ... a Peristaltic and Venturi pump, allowing ... mode for Phaco or Vitrectomy procedures.,The ... is a microprocessor-controlled vacuum system that ...
Medicine Products: